4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000950170-22-025513
10% owner acquired 888,130 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · 10% owner
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-11-17 | Conversion : show line 1 in the form | +888,130 | 888,130 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-11-17 | Conversion : show line 2 in the form Series B Preferred Stock | −2,190,131 | 0 | D |
Loading xslF345X03/ownership.xml…